Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce

January 11, 2025

Ark Invest, led by Cathie Wood, made significant trades in 5 companies on Friday: RXRX, ILMN, NTLA, NET, and ADPT.

Via Benzinga

Topics Workforce

AI Drug Discovery Stocks: Recursion Pharmaceuticals Has A Long Road Ahead

January 07, 2025

Among the various use-cases for AI, healthcare has been one of the interesting ones. Recursion Pharmaceuticals (RXRX) is one such notable player in the industry that has successfully leveraged AI in...

Via Talk Markets

Topics Artificial Intelligence Stocks / Equities

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

January 07, 2025

Recursion to Present at 43rd Annual JP Morgan Healthcare Conference

January 06, 2025

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

December 21, 2024

Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note

(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest

November 28, 2024

Via Benzinga

January 04, 2025

On Friday, Cathie Wood-led Ark Invest made significant trades involving PLTR, ARKB, and QSI. The PLTR trade sold shares worth $1.6 million, aligning with Ark's trend of reducing their position in the...

Via Benzinga

Topics Artificial Intelligence ETFs

Nio, Unity Software And Other Big Stocks Moving Higher On Thursday

January 02, 2025

Via Benzinga

1 Artificial Intelligence (AI) Stock That Could Soar in 2025

December 21, 2024

Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Topics Artificial Intelligence

December 20, 2024

Recursion on Tuesday held a webinar to discuss results from the Phase 1/2 study of REC-617, a selective CDK7 inhibitor, in advanced solid tumors. The results were presented at an AACR Special...

10 Health Care Stocks Whale Activity In Today's Session

December 11, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session

December 10, 2024

Via Benzinga

What's Going On With Recursion Pharmaceuticals Stock?

December 10, 2024

Via Benzinga

Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class CDK7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability

December 09, 2024

From Recursion Pharmaceuticals, Inc.

An Investor's Guide to the Artificial Intelligence (AI) Value Chain

December 09, 2024

Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday

Topics Artificial Intelligence

December 06, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session

December 04, 2024

Via Benzinga

Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That’s Expected to be a $7.2 Billion Market by 2029

December 04, 2024

EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:ISRG) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Berkshire Hathaway Isn't the Only Publicly Traded Company That Buys Stocks. These 3 Tech Giants Also Have Stock Portfolios.

December 04, 2024

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

December 03, 2024

From Recursion Pharmaceuticals, Inc.

Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.

XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday

December 02, 2024

Via Benzinga

NVIDIA Invested in These 2 AI Stocks, Should You?

December 02, 2024

Via MarketBeat

Topics Artificial Intelligence

Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One

November 27, 2024

Jim Cramer praises Reddit, Inc. but warns of auto parts made in China. Recursion Pharmaceuticals and Dow Inc. face challenges. Super Micro Computer sells due to accounting irregularities.

Via Benzinga

Topics Stocks

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

November 26, 2024

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Via Benzinga

Topics Artificial Intelligence

2 Innovative Stocks That Could Deliver Outsize Returns

November 22, 2024

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

November 20, 2024

From Recursion Pharmaceuticals, Inc.

Nvidia's purchase of 7.72 million shares of Applied Digital boosted the company's revenue and earnings. Applied Digital plans to expand its data centers and AI cloud infrastructure.

Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars

November 15, 2024

Via Benzinga

Topics Artificial Intelligence

Nvidia Discloses Stake In Applied Digital, Keeps Arm, SoundHound Stakes

November 15, 2024

Nvidia has disclosed an investment in Applied Digital, a digital infrastructure provider. Nvidia stock dipped while APLD stock rose.

Via Investor's Business Daily

Recursion and Exscientia Shareholders Approve the Proposed Combination

November 13, 2024

Update call scheduled for November 20th at 7:30 a.m. Eastern with anticipated close